Your browser doesn't support javascript.
loading
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.
Fucà, Giovanni; Galli, Giulia; Poggi, Marta; Lo Russo, Giuseppe; Proto, Claudia; Imbimbo, Martina; Ferrara, Roberto; Zilembo, Nicoletta; Ganzinelli, Monica; Sica, Antonio; Torri, Valter; Colombo, Mario Paolo; Vernieri, Claudio; Balsari, Andrea; de Braud, Filippo; Garassino, Marina Chiara; Signorelli, Diego.
Affiliation
  • Fucà G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Galli G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Poggi M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Lo Russo G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Proto C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Imbimbo M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Ferrara R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Zilembo N; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Ganzinelli M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Sica A; Department of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale 'Amedeo Avogadro', Novara, Italy.
  • Torri V; Department of Oncology and Hematology, Humanitas Clinical and Research Center, Rozzano, Italy.
  • Colombo MP; Laboratory of Methodology for Biomedical Research, IRCCS Mario Negri Institute for Pharmacological Research, Milan, Italy.
  • Vernieri C; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Balsari A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • de Braud F; Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy.
  • Garassino MC; Dipartimento di Scienze Biomediche per la Salute, University of Milan, Milan, Italy.
  • Signorelli D; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
ESMO Open ; 4(1): e000457, 2019.
Article in En | MEDLINE | ID: mdl-30964126
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: ESMO Open Year: 2019 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: ESMO Open Year: 2019 Document type: Article Affiliation country: Italy Country of publication: United kingdom